Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.
Head-to-head
CoreAge Rx vs Omzo
CoreAge Rx and Omzo both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Visit CoreAge RxOmzo
Ranked #243 · Grade C
Best for: A mother budgeting twelve months who wants a published schedule, even if she has to open a legal page to find it.
Visit OmzoThe verdict
CoreAge Rx edges out Omzo on the Rx-Readiness Score, 95 to 49 (A vs C). Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Omzo is still a genuine option — cost a year out and the banner stops helping. A first month of $199 plus eleven at $299 is $3,488 for semaglutide; the "$179" on the front page never appears on a bill. Tirzepatide is $349 then $399, so $4,738. The prices are real and itemized — they are just in the Terms and Conditions rather than on a pricing page, and the tirzepatide figure the homepage advertises is not in that schedule at all. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | Omzo |
|---|---|---|
| Rx-Readiness Score | 95/100 · A | 49/100 · C |
| Overall rank | #1 | #243 |
| Semaglutide | $99/mo | $299/mo |
| Tirzepatide | $149/mo | $399/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat monthly price that stays put through titration — no dose-scaling surprise on your busiest month
- Both compounded semaglutide and tirzepatide on one plan, so you're not re-signing to switch
- Async, no-video intake and all-50-states coverage — start it during a lunch break
The caveats
- Not the rock-bottom sticker price — a couple of teaser tiers elsewhere start lower
- Compounded only — no FDA-approved brand option
- General metabolic program, not a boutique concierge service
Omzo
Ranked #243 · Grade C
What we like
- Six packages, each with a first-month and an ongoing price, all published
- Consultation, prescription, medication, shipping and ongoing support are named as included in each
- Explicit about compounding: not FDA-approved, not reviewed for safety or quality, no equivalence claimed
The caveats
- The advertised $179 is 40% below the $299 that applies from month two
- "Originally priced at $179, currently offered at $199" is an increase written as a markdown
- $279, the homepage's tirzepatide figure, is not in the schedule in any position
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Omzo against other providers on our shortlist.
Or browse the full comparison hub.